Craft

Biostage

Stock Price

$5.9

2023-09-20

Market Capitalization

$63.9 M

2023-09-20

Biostage Summary

Company Summary

Overview
Biostage is a biotechnology company developing bio engineered organ implants based on its novel Cellframe technology. The Company's Cellframe technology is comprised of a biocompatible scaffold seeded with the patient’s own stem cells. Biostage is pursuing the Cellspan esophageal implant as its first product candidate to address esophageal atresia and esophageal cancer and is also developing its technology’s applications to address conditions of the bronchus and trachea. 
Type
Public
Status
Active
Founded
2012
HQ
Holliston, MA, US | view all locations
Website
http://www.biostage.com/
Cybersecurity rating
Sectors

Key People

  • David Green
  • Hong Yu
  • Shunfu Hu

    Shunfu Hu, VP of Business Development and Operations

  • William Fodor

    William Fodor, Chief Scientific Officer

LocationsView all

1 location detected

  • Holliston, MA HQ

    United States

    84 October Hill Rd

Biostage Financials

Summary Financials

Revenue (Q3, 2023)
$40.0K
Net income (Q3, 2023)
($1.6M)
Cash (Q3, 2023)
$269.0K
EBIT (Q3, 2023)
($1.6M)
Enterprise value
$63.7M

Footer menu